AzTrials
AzTrials

AnxietyHYPNOLINENCT05999578

Contribution of Hypnosis on Image Quality in Cardiac MRI

A study testing Hypnosis in people with Anxiety, run by University Hospital, Bordeaux at 1 site in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The present project aims to explore the effect of a hypnosis session performed on a patient with anxiety during a cardiac MRI examination on image quality. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Anxiety
What is being tested?
Hypnosis
Could I receive a placebo?
No, everyone receives an active treatment
How many people
90 participants
Where
1 siteFrance
Study dates
15 Apr 2025to May 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Anxious patient (anxiety score TRAIT (baseline) and anxiety score STATE (situational) ≥ 46) and non-anxious patient (anxiety score TRAIT and anxiety score STATE < 46) requiring cardiac MRI for diagnosis or follow-up of a cardiac pathology except the patients with cardiac arrhythmias or irregular heartbeats.
  • 18 years and older
  • Highly effective contraception for women of childbearing potential, maintained during research procedures
  • Informed consent
  • Affiliated or beneficiary of health insurance

Who cannot join

  • Contraindications to MRI and gadoline contrast medium
  • Hearing impaired patients
  • Patients who do not speak French
  • Women who are pregnant or lactating
  • Inability to agree to participate to the study
  • Patient under legal protection

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

France1 site, 1 recruiting
  • CHU Bordeaux

    Bordeaux

    Amandine ANDRE-BILLEAU, +33557820000 ext. 74634, amandine.andre@chu-bordeaux.fr

    Recruiting

Other trials in France

About this study

Official title: Evaluating the Contribution of Hypnosis on Image Quality During Cardiac Magnetic Resonance Imaging (MRI) in Anxious Patients

The present project aims to explore the effect of a hypnosis session performed on a patient with anxiety during a cardiac MRI examination on image quality.

Read the detailed description

Cardiac Magnetic Resonance Imaging (MRI) is an activity of the Bordeaux University Hospital that continues to grow (+7.3% in 2021 compared to 2019) under the combined effect of the increase in activity of cardiology care channels and the extension of clinical indications for cardiac MRI. Indeed, cardiac MRI has become an essential examination in the diagnosis of many heart diseases and is little practiced elsewhere in New Aquitaine. The current delay for a cardiac MRI is 3 and a half months.

In this context, it is necessary to be efficient because any procedure failure, examination interruption or insufficient image quality can delay the diagnosis and therapeutic management of the patient for several months. Numerous studies have shown that anxiety induces interruptions in the acquisition of MRI images and repetition of sequences, thus prolonging the examination time.

However, no study takes into account the specificity of cardiac MRI, whose image quality is intimately linked to the patient's cooperation and to the synchronization of the sequences with the heart rhythm.

Hypnosis seems to be adapted to reduce the patient's anxiety, by allowing him to ignore the surrounding reality while remaining in relation with the attendant.

The hypothesis is that by reducing patient anxiety through hypnosis, image quality in cardiac MRI would be improved.

Conditions
Anxiety
Being tested
Hypnosis
Keywords
hypnosis, cardiac MRI, anxiety
Medical subject headings
Anxiety Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • HypnosisOther

    Hypnosis support before, during and at the end of cardiac MRI exam

Study groups in NCT05999578
Study groupRoleWhat they receive
Anxious patients with hypnosisExperimentalHypnosis support before, during and at the end of cardiac MRI exam
Receives: Other: Hypnosis
Anxious patients without hypnosisNo interventionCardiac MRI exam accordingly to usual care
Non anxious patientsNo interventionCardiac MRI exam accordingly to usual care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. quality of cardiac MRI images

    Likert score measurements

    Measured: Baseline

Secondary outcomes (7)
  1. number of artifacts

    The number of artifacts will be estimated with European CMR Registry objective score.

    Measured: Baseline

  2. Diagnostic validation score

    The diagnostic validation score for the entire examination (and not sequence by sequence) makes it possible to define whether, despite the presence of artifacts, the examination makes it possible to answer the question initially asked in the examination request.

    Measured: Baseline

  3. Causality score measurement

    Causality score measurement for examinations with a Likert score < 4

    Measured: Baseline

  4. Overall duration

    The overall duration of the examination and the different phases (reception and preparation time, image acquisition time).

    Measured: Baseline

  5. Number of repeated or interrupted sequences

    The number of repeated or interrupted sequences (by the Radiographer or the patient).

    Measured: Baseline

  6. Anxiety level

    The Spielberg State Anxiety Index STAI-Y anxiety score will be used to estimate patient anxiety before and after the MRI.

    Measured: Baseline

  7. Post-MRI satisfaction score

    The post-MRI satisfaction score will be estimated from the patient by a visual analog scale rated from 0 (not at all satisfied) to 10 (very satisfied).

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Aug 2023
  2. Study start15 Apr 2025
  3. Primary completionMay 2027 (estimated)
  4. Study completionMay 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
90 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05999578
Sponsor's protocol ID
CHUBX 2022/79
Acronym
HYPNOLINE
Status last verified
Sep 2025
First submitted
11 Aug 2023
Last updated
15 Sep 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Hypnosis in people with Anxiety, run by University Hospital, Bordeaux at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 15 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Amandine ANDRE-BILLEAU (+33557820000 ext. 74634, amandine.andre@chu-bordeaux.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

quality of cardiac MRI images (time frame: Baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in